首页> 外文期刊>Journal of the American Geriatrics Society >Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE‐Cog Field Trial
【24h】

Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE‐Cog Field Trial

机译:用于支持痴呆症的干预和愿景的可行性:感觉COG实地试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives People with dementia (PwD) frequently experience hearing and vision impairment that is underrecognized and undertreated, resulting in reduced quality of life. Managing these impairments may be an important strategy to improve outcomes in PwD. Our objective was to field‐trial a multifaceted sensory intervention (SI) to enhance hearing and vision in PwD. Design An international single‐arm open‐label feasibility, acceptability, and tolerability study. Setting Home‐based setting in the United Kingdom, France, and Cyprus. Participants Adults aged 60 years and older with mild‐to‐moderate dementia and uncorrected or suboptimally corrected hearing and/or vision impairment, and their study partners (n?=?19 dyads). Intervention A sensory intervention (SI), comprising assessment of hearing and vision, fitting of corrective devices (glasses, hearing aids), and home‐based support from a sensory support therapist for device adherence and maintenance, communication training, referral to support services, environmental sensory modification, and optimization of social inclusion. Measurements Ratings of study procedure feasibility, and intervention acceptability/tolerability, ascertained through questionnaires, participant diaries, therapist logbooks, and semistructured interviews. Results We successfully delivered all intervention components, and these were received and enacted as intended in all those who completed the intervention. No serious adverse events were reported. Acceptability (ie, understanding, motivation, sense of achievement) and tolerability (ie, effort, fatigue) ratings of the intervention were within a priori target ranges. We met recruitment and retention (93.8%) targets in two of the three sites. Participants completed more than 95% of diary entries, representing minimal missing data. Delays in the logistics circuit for the assessment and delivery of hearing aids and glasses were identified, requiring modification. The need for minor modifications to some outcome measures and the inclusion criteria were identified. Conclusion This is the first study combining home‐based hearing and vision remediation in PwD. The positive feasibility, acceptability, and tolerability findings suggest that a full‐scale efficacy trial, with certain modifications, is achievable.
机译:目标患有痴呆症(PWD)的人经常经历听力和视力障碍,这些障碍是令人印象因和下降的,导致生活质量降低。管理这些损害可能是改善PWD成果的重要策略。我们的目标是脱田 - 试验多方面的感官干预(SI),以加强PWD的听力和愿景。设计国际单臂开放标签可行性,可接受性和可耐受性研究。在英国,法国和塞浦路斯设定基于家庭的环境。参与者成年人60岁及以上年龄较大,具有轻度至中度的痴呆和未纠正的或潜在纠正的听证会和/或视觉障碍,以及他们的研究合作伙伴(n?= 19个dyads)。干预感觉干预(SI),包括评估听力和愿景,纠正装置(眼镜,助听器)和来自感官支持治疗师的家庭支持,用于设备遵守和维护,通信培训,推荐支持服务,环境感官修改,社会包容性的优化。测量研究程序的评级可行性,干预可接受性/可耐受性,通过调查问卷,参与者日记,治疗师日志和半系统的访谈确定。结果我们成功交付了所有干预组成部分,这些组成部分是在完成干预的所有人中收到和颁布的。没有报道任何严重的不良事件。可接受性(即,理解,动机,成就感)和潜在介入的侵害性(即努力,疲劳)在先验目标范围内。我们在三个地点中的两场招募和保留(93.8%)目标。参与者完成了超过95%的日记参赛作品,代表了最小的缺失数据。确定了用于评估和交付助听器和眼镜的物流电路的延迟,需要修改。确定了对某些结果措施和纳入标准进行轻微修改的必要性。结论这是第一项研究基于家庭的听力和愿景在PWD中的研究。积极的可行性,可接受性和耐受性调查结果表明,具有一定修改的全规模疗效试验是可实现的。

著录项

  • 来源
  • 作者单位

    Faculty of Biology Medicine and Health Division of Neuroscience and Experimental;

    Faculty of Biology Medicine and Health Division of Neuroscience and Experimental;

    University of South FloridaTampa Florida;

    Manchester Centre for Health Economics School of Health SciencesUniversity of ManchesterManchester;

    Department of Health Sciences School of SciencesEuropean University CyprusNicosia Cyprus;

    INSERM EUCLID/F‐CRIN Clinical Trials Platform Bordeaux Population Health Center CHU Bordeaux F;

    Department of Psychology and Center for Applied NeuroscienceUniversity of CyprusNicosia Cyprus;

    Manchester Centre for Audiology and DeafnessUniversity of ManchesterManchester United Kingdom;

    Manchester Centre for Health Economics School of Health SciencesUniversity of ManchesterManchester;

    Starkey Hearing TechnologiesStockport United Kingdom;

    INSERM EUCLID/F‐CRIN Clinical Trials Platform Bordeaux Population Health Center CHU Bordeaux F;

    Centre for BiostatisticsUniversity of ManchesterManchester United Kingdom;

    INSERM Bordeaux Population Health Research Center Team LEHAUniversity of BordeauxBordeaux France;

    Catholic University of Applied Sciences FreiburgFreiburg Germany;

    Manchester Centre for Health Economics School of Health SciencesUniversity of ManchesterManchester;

    Essilor InternationalResearch &

    DevelopmentParis France;

    Essilor InternationalResearch &

    DevelopmentParis France;

    Centre for BiostatisticsUniversity of ManchesterManchester United Kingdom;

    University of ManchesterManchester United Kingdom;

    Department of Health Sciences School of SciencesEuropean University CyprusNicosia Cyprus;

    Catholic University of Applied Sciences FreiburgFreiburg Germany;

    Faculty of Biology Medicine and Health Division of Neuroscience and Experimental;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 老年病学;
  • 关键词

    dementia; hearing and vision impairments; feasibility; acceptability; tolerability;

    机译:痴呆症;听力和视力障碍;可行性;可接受性;可耐受性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号